Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a routine software update or patch to the page. This does not alter the displayed study information.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page revision changed from v3.6.4 to v3.6.5, indicating a small update to the page metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows a new revision line 'Revision: v3.6.4' replacing 'Revision: v3.6.3'. This indicates a minor update to the page without changes to the study content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision indicator was updated to v3.6.3, representing a backend page update. There are no changes to the study details or navigation presented to users.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor site update without substantive changes to the study content. This appears to be a maintenance/patch update rather than a content change.SummaryDifference0.1%

- Check92 days agoChange DetectedNew investigator and verification metadata appear (Yanhong Deng and Last verified), refreshing credibility details. New navigation items (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were added, and formatting tweaks to labels (e.g., 'Last known status was' and 'Intervention/Treatment') were applied.SummaryDifference2%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.